Europe Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity

March 2022 | 140 pages | ID: E8E5642764DBEN
GMD Research

Abstracts

Europe pharmaceutical contract research organization (CRO) market was valued at $12.13 billion in 2021 and will grow by 9.6% annually over 2021-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.

Highlighted with 69 tables and 48 figures, this 140-page report “Europe Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.

Based on Service, the Europe market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.

• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services

Based on Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.

• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.

• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

Geographically, the following national/local markets are fully investigated:

• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

• Charles River Laboratories
• CMIC Co. Ltd
• Covance Inc.
• Hangzhou Tigermed Consulting Co., Ltd.
• ICON Plc
• IQVIA Holdings Inc.
• LSK Europe Pharma Service Co., Ltd.
• Novotech Pty Ltd
• PAREXEL International Corporation
• Pharmaceutical Product Development LLC (PPD)
• PRA Health Sciences Inc.
• Quanticate Ltd
• Samsung Bioepis Co., Ltd.
• SGS SA (SGS Life Sciences)
• Syneos Health Inc.
• WuXi AppTec Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF EUROPE MARKET BY SERVICE

3.1 Market Overview by Service
3.2 CRO for Pre-clinical Development
3.3 CRO for Phase I Trials
3.4 CRO for Phase II Trials
3.5 CRO for Phase III Trials
3.6 CRO for Phase IV Trials
3.7 Laboratory Services
3.8 Consulting Services
3.9 Data Management Services

4 SEGMENTATION OF EUROPE MARKET BY THERAPEUTIC APPLICATION

4.1 Market Overview by Therapeutic Application
4.2 Infectious Diseases
4.3 Oncology
4.4 Metabolic Disorders
4.5 Cardiovascular Disorders
4.6 Central Nervous System
4.7 Respiratory Disorders
4.8 Gastrointestinal Disorders
4.9 Other Therapeutic Applications

5 SEGMENTATION OF EUROPE MARKET BY END USER

5.1 Market Overview by End User
5.2 Pharmaceutical & Biopharmaceutical Companies
5.3 Medical Device Companies
5.4 Academic Institutes

6 EUROPEAN MARKET 2019-2030 BY COUNTRY

6.1 Overview of European Market
6.2 Germany
6.3 UK
6.4 France
6.5 Spain
6.6 Italy
6.7 Russia
6.8 Rest of European Market

7 COMPETITIVE LANDSCAPE

7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.

8 INVESTING IN EUROPE MARKET: RISK ASSESSMENT AND MANAGEMENT

8.1 Risk Evaluation of Europe Market
8.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Europe Pharmaceutical CRO Market in Balanced Perspective, 2019-2030
Table 2. World Economic Outlook, 2021-2031
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. Worldwide Total Number of Registered Clinical Trials
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. Main Product Trends and Market Opportunities in Europe Pharmaceutical CRO Market
Table 7. Europe Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 8. Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 9. Europe Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 10. Europe Pharmaceutical CRO Market by Country, 2019-2030, $ bn
Table 11. Germany Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 12. Germany Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 13. Germany Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 14. UK Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 15. UK Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 16. UK Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 17. France Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 18. France Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 19. France Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 20. Spain Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 21. Spain Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 22. Spain Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 23. Italy Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 24. Italy Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 25. Italy Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 26. Russia Pharmaceutical CRO Market by Service, 2019-2030, $ bn
Table 27. Russia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn
Table 28. Russia Pharmaceutical CRO Market by End User, 2019-2030, $ bn
Table 29. Pharmaceutical CRO Market in Rest of Europe by Country, 2019-2030, $ bn
Table 30. Breakdown of World Market by Key Vendor, 2020, %
Table 31. Charles River Laboratories: Company Snapshot
Table 32. Charles River Laboratories: Product Portfolio
Table 33. CMIC Co. Ltd.: Company Snapshot
Table 34. CMIC Co. Ltd.: Business Segmentation
Table 35. CMIC Co. Ltd.: Revenue by Region, 2018, %
Table 36. Covance Inc.: Company Snapshot
Table 37. Covance Inc.: Product Portfolio
Table 38. Covance Inc.: Revenue by Region, 2020, %
Table 39. Hangzhou Tigermed Consulting Co., Ltd.: Company Snapshot
Table 40. Hangzhou Tigermed Consulting Co., Ltd.: Business Segmentation
Table 41. ICON Plc: Company Snapshot
Table 42. ICON Plc: Business Segmentation
Table 43. ICON Plc: Product Portfolio
Table 44. ICON Plc: Revenue by Region, 2020, %
Table 45. IQVIA Holdings Inc.: Company Snapshot
Table 46. IQVIA Holdings Inc.: Business Segmentation
Table 47. IQVIA Holdings Inc.: Revenue by Region, 2020, %
Table 48. IQVIA Holdings Inc.: Product Portfolio
Table 49. LSK Global Pharma Service Co., Ltd.: Company Snapshot
Table 50. Novotech Pty Ltd: Company Snapshot
Table 51. PAREXEL International Corporation: Company Snapshot
Table 52. PAREXEL International Corporation: Business Segmentation
Table 53. PAREXEL International Corporation: Revenue by Region, 2018, %
Table 54. PAREXEL International Corporation: Product Portfolio
Table 55. Pharmaceutical Product Development LLC (PPD): Company Snapshot
Table 56. PRA Health Sciences Inc.: Company Snapshot
Table 57. PRA Health Sciences Inc.: Business Segmentation
Table 58. PRA Health Sciences Inc.: Revenue by Region, 2018, %
Table 59. Quanticate Ltd: Company Snapshot
Table 60. Samsung Bioepis Co., Ltd.: Company Snapshot
Table 61. SGS SA (SGS Life Sciences): Company Snapshot
Table 62. SGS SA (SGS Life Sciences): Business Segmentation
Table 63. SGS SA (SGS Life Sciences): Revenue by Region, 2018, %
Table 64. Syneos Health Inc.: Company Snapshot
Table 65. Syneos Health Inc.: Business Segmentation
Table 66. Syneos Health Inc.: Revenue by Region, 2018, %
Table 67. WuXi AppTec Inc.: Company Snapshot
Table 68. Risk Evaluation for Investing in Europe Market, 2021-2030
Table 69. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2030
Figure 5. Europe Pharmaceutical CRO Market, 2019-2030, $ bn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Europe Pharmaceutical CRO Market
Figure 8. Leading Causes of Death in the World, 2019-2020, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Europe Pharmaceutical CRO Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Europe Pharmaceutical CRO Market
Figure 14. Breakdown of Europe Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue
Figure 15. Europe Addressable Market Cap in 2022-2030 by Service, Value ($ bn) and Share (%)
Figure 16. Europe Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn
Figure 17. Europe Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn
Figure 18. Europe Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn
Figure 19. Europe Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn
Figure 20. Europe Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn
Figure 21. Europe Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn
Figure 22. Europe Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn
Figure 23. Europe Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn
Figure 24. Breakdown of Europe Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue
Figure 25. Europe Addressable Market Cap in 2022-2030 by Therapeutic Application, Value ($ bn) and Share (%)
Figure 26. Europe Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn
Figure 27. Europe Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn
Figure 28. Europe Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn
Figure 29. Europe Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn
Figure 30. Europe Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn
Figure 31. Europe Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn
Figure 32. Europe Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn
Figure 33. Europe Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn
Figure 34. Breakdown of Europe Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue
Figure 35. Europe Addressable Market Cap in 2022-2030 by End User, Value ($ bn) and Share (%)
Figure 36. Europe Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn
Figure 37. Europe Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn
Figure 38. Europe Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn
Figure 39. Breakdown of European Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue
Figure 40. Contribution to Europe 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 41. Pharmaceutical CRO Market in Germany, 2019-2030, $ bn
Figure 42. Pharmaceutical CRO Market in UK, 2019-2030, $ bn
Figure 43. Pharmaceutical CRO Market in France, 2019-2030, $ bn
Figure 44. Pharmaceutical CRO Market in Spain, 2019-2030, $ bn
Figure 45. Pharmaceutical CRO Market in Italy, 2019-2030, $ bn
Figure 46. Pharmaceutical CRO Market in Russia, 2019-2030, $ bn
Figure 47. Pharmaceutical CRO Market in Rest of Europe, 2019-2030, $ bn
Figure 48. Growth Stage of Europe Pharmaceutical CRO Industry over the Forecast Period